Viking Global Investors’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,934,914	Closed	-$61.6M	–	91
2024 Q2	$61.6M	Hold	2,934,914	–	–	0.24%	66
2024 Q1	$93.5M	Sell	2,934,914 -1,853,000	-39%	-$47.3M	0.35%	56
2023 Q4	$97M	Hold	4,787,914	–	–	0.36%	56
2023 Q3	$61M	Hold	4,787,914	–	–	0.25%	60
2023 Q2	$86.5M	Buy	4,787,914 +850,000	+22%	+$15.6M	0.35%	57
2023 Q1	$67.7M	Hold	3,937,914	–	–	0.32%	56
2022 Q4	$87.5M	Hold	3,937,914	–	–	0.44%	50
2022 Q3	$31.7M	Hold	3,937,914	–	–	0.15%	74
2022 Q2	$27.5M	Hold	3,937,914	–	–	0.13%	75
2022 Q1	$59.5M	Hold	3,937,914	–	–	0.24%	73
2021 Q4	$86.4M	Hold	3,937,914	–	–	0.25%	75
2021 Q3	$106M	Hold	3,937,914	–	–	0.29%	69
2021 Q2	$94.8M	Hold	3,937,914	–	–	0.29%	64
2021 Q1	$171M	Hold	3,937,914	–	–	0.51%	52
2020 Q4	$163M	Buy	+3,937,914	New	+$163M	0.45%	56